TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia

Blood

Volumn 88, Issue 11, 1996, Pages 4252-4258

  McLean, Thomas W ^b   Ringold, Sarah ^b   Neuberg, Donna ^b   Stegmaier, Kimberly ^b   Tantravahi, Ramana ^b   Ritz, Jerome ^b   Koeffler, H Phillip ^b   Takeuchi, Seisho ^b   Janssen, Johannes W G ^b   Seriu, Taku ^b   Bartram, Claus R ^b   Sallan, Stephen E ^b   Gilliland, D Gary ^b   Golub, Todd R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; FEMALE; GENE FUSION; GENETIC TRANSFORMATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RELAPSE;

EID: 0007055492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4252.bloodjournal88114252     Document Type: Article

References (48)

1. Young JL, Ries LG, Silverberg E, Horm JW, Miller RW: Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58:598, 1986
2. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE: Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 12:740, 1994
3. Pui C-H, Simone JV, Hancock ML, Evans EV, Williams DL, Bowman WP, Dahl GV, Dodge RK, Ochs J, Abromowitch M, Rivera GK: Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: Long-term results of St. Jude Total Therapy Study X. Leukemia 6:150, 1992
4. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR: Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86:38, 1995
5. Takeuchi S, Bartram C, Miller C, Reiter A, Seriu T, Zimmerman M, Schrappe M, Mori N, Slater J, Miyoshi I, Koeffler HP: Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 87:3368, 1996
6. KIP1. Blood 86:3869, 1995
7. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Roberts JM, Trask BJ, Le Beau MM, Vogelstein B, Rowley JD, Bohlander SK: TEL and KIP1 define the smallest region of deletions in 12p13 in hematopoietic malignancies. Blood 86:1525, 1995
8. Polyak K, Lee M, Erdjument-Bromage H, Koff A, Roberts J, Tempst P, Massague J: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59, 1994
9. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclincdk protein kinase activity, is related to p21. Cell 78:67, 1994
10. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell 77:307, 1994
11. Golub TR, Barker GF, Bohlander SK, Hiebert S, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917, 1995
12. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel A, Riegman P, Deprez R, Zwarhoff E, Hagemeijer A, Grosfeld G: Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10:1511, 1995
13. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
14. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx R, La Starza R, Aventin A, Bosley A, Martelli MF, Cassiman JJ, Van den Berghe H: TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant (10;12)(q24;p13). Blood 85:2848, 1995
15. Knudson AG: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820, 1971
16. Stegmaier K, Takeuehi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP. Gilliland DG: Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res 56:1413, 1996
17. Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B. Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Vogelstein B: Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55:1206, 1995
18. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA: The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 85:3662, 1995
19. Mitelman F: Catalog of Chromosome Aberrations in Cancer. New York, NY, Liss, 1994
20. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Muller U, Lunscken C, Fulle H, Ho R, Kuchler R, Busch FW, Schneider W, Gorg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123, 1988
21. Maurer J, Janssen JWG, Thiel E, van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reaction. Lancet 337:1055, 1991
22. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
23. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF: Clonality in mycloproliferative disorders: Analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 88:6848, 1991
24. Janssen JWG, Fonatsch C, Ludwig W-D, Rieder H, Maurer J, Bartram CR: Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients. Leukemia 6:463, 1992
25. Meyers S, Lenny N, Hiebert S: The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 15:1974, 1995
26. Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, Wigler M: Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol 8:2159, 1988
27. Ravichandran KS, Burakoff SJ: The adapter protein she interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem 269:1599, 1994
28. Rosner B: Fundamentals of Biostatistics. Boston, MA, PWS Kent, 1991
29. Sallan SE, Clavell JR, Gelber R, Hitchcock-Bryan S, Cassady JR: Intensive chemotherapy in childhood acute lymphoblastic leukemia, in Wehinger J (ed): Current Therapy of Leukemia in Childhood, An International Symposium at Bad Karlshafen, Friedrichsdorf, Germany, 1984, p 34
30. Niemeyer CM, Gelber RD, Tarbell NJ, Donnelly M, Clavell LA, Blattner SR, Donahue K, Cohen HJ, Sallan SE: Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update). Blood 78:2514, 1991
31. Billett AL, Gelber RD, Tarbell NJ, Barr R, Blattner S, Clavell L, LeClerc JM, Lipton J, Schwenn M, Schorin M, Cohen HJ, Sallan SE: Sex differences in the risk of central nervous system relapse in childhood acute lymphoblastic leukemia. Proc Amer Soc Clin Oncol 12:317, 1993 (abstr)
32. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
33. Miyoshi H, Ohira M, Shimizu S, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M: Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 23:2762, 1995
34. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
35. Nourse J, Mellentin J, Galili N, Wilkinson J, Stanbridge E, Smith S, Cleary M: Chromosomal translocation t(1:19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535, 1990
36. Romana SP, Poirel H, Leconiat M, Flexor M-A, Machauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of the t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263, 1995
37. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E. Marynen P, Grandchamp B: The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891, 1996
38. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui C, Grosveld G, Downing JR: TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985, 1995
39. Golub TR, Goga A, Barker GF, Afar DEH, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
40. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA: Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13:3324, 1993
41. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431, 1991
42. Nisson PE, Watkins PC, Sacchi N: Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8:21) leukemic cells. Cancer Genet Cytogenet 63:81, 1992
43. Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD: The 3:21 translocalion in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc Natl Acad Sci USA 90:7784, 1993
44. Nucifora G, Begy C, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle J, Rowley J: Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26:q22) translocations. Proc Natl Acad Sci USA 91:4004, 1994
45. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H: Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504, 1994
46. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS: Fusion between transcription factor CBFB/PEBP2B and a myosin heavy chain in acute myeloid leukemia. Science 261:1041, 1993
47. Klambt C: The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells. Development 117:163, 1993
48. Hiebert SW, Sun W-H, Davis N, Golub TR, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussel M, Gilliland DG, Lenny N, Meyers S: The t(12;21) converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349, 1996